114 related articles for article (PubMed ID: 27156793)
1. Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples.
Latsuzbaia A; Tapp J; Nguyen T; Fischer M; Arbyn M; Weyers S; Mossong J
Diagn Microbiol Infect Dis; 2016 Jul; 85(3):318-322. PubMed ID: 27156793
[TBL] [Abstract][Full Text] [Related]
2. HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.
Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN
Papillomavirus Res; 2017 Dec; 4():79-84. PubMed ID: 29179874
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
Kwon MJ; Roh KH; Park H; Woo HY
J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of Anyplex II HPV28 and Allplex HPV28 molecular assays for human papillomavirus detection and genotyping in anogenital cancer screening.
Naegele K; Bubendorf L; Hirsch HH; Leuzinger K
J Med Virol; 2024 Jun; 96(6):e29649. PubMed ID: 38812416
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
6. Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
Cornall AM; Poljak M; Garland SM; Phillips S; Tan JH; Machalek DA; Quinn MA; Tabrizi SN
Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):545-551. PubMed ID: 27822653
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus.
Pasquier C; Sauné K; Raymond S; Boisneau J; Courtade M; Izopet J
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):25-27. PubMed ID: 28336133
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
Oštrbenk A; Xu L; Arbyn M; Poljak M
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30209184
[TBL] [Abstract][Full Text] [Related]
9. Performance evaluation of Anyplex™II HPV28 detection kit in a routine diagnostic setting: comparison with the HPV Sign® Genotyping Test.
Marcuccilli F; Farchi F; Mirandola W; Ciccozzi M; Paba P; Bonanno E; Perno CF; Ciotti M
J Virol Methods; 2015 Jun; 217():8-13. PubMed ID: 25724435
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping.
Kim M; Kim J; Park NJ; Park JY
PLoS One; 2022; 17(7):e0267836. PubMed ID: 35802570
[TBL] [Abstract][Full Text] [Related]
11. Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples.
Bell M; Verberckmoes B; Devolder J; Vermandere H; Degomme O; Guimarães YM; Godoy LR; Ambrosino E; Cools P; Padalko E
Microbiol Spectr; 2023 Aug; 11(4):e0008123. PubMed ID: 37284753
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four assays for human papillomavirus detection in the anal canal.
Poynten IM; Jin F; Molano M; Machalek DA; Roberts JM; Hillman RJ; Cornall A; Phillips S; Templeton DJ; Law C; Fairley CK; Grulich AE; Garland SM;
Clin Microbiol Infect; 2022 Dec; 28(12):1652.e1-1652.e6. PubMed ID: 35809783
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of HPV Genotyping Assays for Archival Clinical Samples.
Lillsunde Larsson G; Carlsson J; Karlsson MG; Helenius G
J Mol Diagn; 2015 May; 17(3):293-301. PubMed ID: 25791291
[TBL] [Abstract][Full Text] [Related]
14. High-risk HPV detection and genotyping by APTIMA HPV using cervical samples.
Pyne MT; Hamula CL; Tardif K; Law C; Schlaberg R
J Virol Methods; 2015 Sep; 221():95-9. PubMed ID: 25956671
[TBL] [Abstract][Full Text] [Related]
15. EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):1033-6. PubMed ID: 27048314
[TBL] [Abstract][Full Text] [Related]
16. Assessing the performance and utility of targeted next-generation sequencing for screening and genotyping of human papillomaviruses.
Lee JH; Park YM; Kim J; Kwon GC; Kim SY
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116216. PubMed ID: 38479093
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HPV genotype-specific concordance between EUROArray HPV and HPV 3.5 LCD-Array Kit in cervical samples of 163 patients.
Bräutigam K; Ehret C; Schillinger V; Baum S; Klar M; Köster F; Rody A; Panning M
Arch Gynecol Obstet; 2020 Mar; 301(3):745-751. PubMed ID: 31875249
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping.
Estrade C; Sahli R
J Clin Microbiol; 2014 Feb; 52(2):607-12. PubMed ID: 24478495
[TBL] [Abstract][Full Text] [Related]
19. Characterization and Diversity of 243 Complete Human Papillomavirus Genomes in Cervical Swabs Using Next Generation Sequencing.
Latsuzbaia A; Wienecke-Baldacchino A; Tapp J; Arbyn M; Karabegović I; Chen Z; Fischer M; Mühlschlegel F; Weyers S; Pesch P; Mossong J
Viruses; 2020 Dec; 12(12):. PubMed ID: 33327447
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Three Different Commercial Kits for the Human Papilloma Virus Genotyping.
Lim YK; Choi JH; Park S; Kweon OJ; Park AJ
J Clin Lab Anal; 2016 Nov; 30(6):1110-1115. PubMed ID: 27121347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
